Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-11

FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)

View source ↗

Summary

FDA approved a supplemental application for CLARITIN REDITABS (loratadine) from Bayer Healthcare LLC., enabling a new or revised indication or labeling componen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin RediTabs (Loratadine)

Snippet

SUPPL AP for CLARITIN REDITABS (LORATADINE)